Fig. 10

Prediction and validation of the effect of immunotherapy. A Distribution of ERG scores between responders and non-responders. B ERG score predicts ROC curve for immunotherapy response. C Distribution of TIDE scores between high- and low-risk groups in the TCGA-GBM dataset. D The relationship between ERG scores, ICB response traits, and each stage of the tumor immune cycle. E The plot of the difference in enrichment scores between the high-risk and low-risk groups on the immunotherapy prediction pathway. F The plot of differences between the high-risk and low-risk groups on each step of the cancer-immune cycle. * p < 0.05, ** p < 0.01, *** p < 0.001